7 results on '"Neel Patel"'
Search Results
2. Unidentified Branches of the Posterior Femoral Cutaneous Nerve and Persistent Neuropathy
- Author
-
Michelle R, Jennette, David, Bailey, Neel, Patel, and Elias, Rizk
- Subjects
General Engineering - Abstract
The posterior femoral cutaneous nerve (PFCN) is an extensive nerve with numerous collateral branches which provide cutaneous innervation to 2/3
- Published
- 2022
3. Long-Term Neurological Sequelae Among Severe COVID-19 Patients: A Systematic Review and Meta-Analysis
- Author
-
Urvish K Patel, Neev Mehta, Amrapali Patel, Neel Patel, Juan Fernando Ortiz, Mahika Khurana, Eseosa Urhoghide, Akshada Parulekar, Arpita Bhriguvanshi, Nidhi Patel, Anuja Mahesh Mistry, Rutul Patel, Kogulavadanan Arumaithurai, and Shamik Shah
- Subjects
General Engineering - Abstract
Few studies have thoroughly evaluated the neuro-invasive effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which may contribute to a wide range of sequelae from mild long-term effects like headaches and fatigue to severe events like stroke and arrhythmias. Our study aimed to evaluate the long-term neurological effects of coronavirus disease 2019 (COVID-19) among patients discharged from the hospital. In this systematic review and meta-analysis, we assessed the long-term neurocognitive effects of COVID-19. Post-COVID-19 neurological sequelae were defined as persistent symptoms of headache, fatigue, myalgia, anosmia, dysgeusia, sleep disturbance, issues with concentration, post-traumatic stress disorder (PTSD), suicidality, and depression long after the acute phase of COVID-19. Data from observational studies describing post-COVID-19 neurocognitive sequelae and severity of COVID-19 from September 1, 2019, to the present were extracted following the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol with a consensus of three independent reviewers. A systematic review was performed for qualitative evaluation and a meta-analysis was performed for quantitative analysis by calculating log odds of COVID-19 neurocognitive sequelae. The odds ratio (OR) and 95% confidence interval (CI) were obtained and forest plots were created using random effects models. We found seven studies, out of which three were used for quantitative synthesis of evidence. Of the 3,304 post-COVID-19 patients identified, 50.27% were male with a mean age of 56 years; 20.20% had post-COVID-19 symptoms more than two weeks after the acute phase of infection. Among persistence symptoms, neurocognitive symptoms like headache (27.8%), fatigue (26.7%), myalgia (23.14%), anosmia (22.8%), dysgeusia (12.1%), sleep disturbance (63.1%), confusion (32.6%), difficulty to concentrate (22%), and psychiatric symptoms like PTSD (31%), feeling depressed (20%), and suicidality (2%) had a higher prevalence. In meta-analysis, COVID-19 patients with severe symptoms had higher odds of headache (pooled OR: 4.53; 95% CI: 2.37-8.65; p0.00001; I
- Published
- 2022
4. A Rare Case of Varicella-Zoster Virus Reactivation Following Recovery From COVID-19
- Author
-
Jaimini V Patoliya, Elton Ahadov, Kamal Sharma, Neel Patel, and Hardik D Desai
- Subjects
Dorsum ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,viruses ,Infectious Disease ,Dermatology ,Disease ,030204 cardiovascular system & hematology ,medicine.disease_cause ,Virus ,03 medical and health sciences ,0302 clinical medicine ,Rare case ,Medicine ,In patient ,sars-cov-2 (severe acute respiratory syndrome coronavirus -2) ,varicella-zoster virus ,Chickenpox ,integumentary system ,business.industry ,herpes zoster virus ,General Engineering ,Varicella zoster virus ,virus diseases ,medicine.disease ,covid-19 ,business ,030217 neurology & neurosurgery - Abstract
In patients with coronavirus disease 2019 (COVID-19), various cutaneous symptoms have been observed. Herpes zoster (HZ) is an infectious skin disease caused by the varicella-zoster virus (VZV) that, after a primary chickenpox infection, persists dormant in the dorsal root ganglia of cutaneous nerves. Unusual prolonged dermatological symptoms from recovered COVID-19 patients have rarely been recorded. In this report, we describe a case of HZ following recovery from COVID-19.
- Published
- 2021
5. A Rare Case of Enterococcus gallinarum-Associated Peritonitis and Literature Review
- Author
-
Neel Patel, Suman Khicher, Heba Osman, and Paul Nguyen
- Subjects
medicine.medical_specialty ,daptomycin ,medicine.medical_treatment ,Cefepime ,vancomycin ,Cefazolin ,Peritonitis ,Infectious Disease ,030204 cardiovascular system & hematology ,Gastroenterology ,Peritoneal dialysis ,03 medical and health sciences ,0302 clinical medicine ,Enterococcus gallinarum ,multi-drug resistant organism (mdro) ,Internal medicine ,vancomycin resistant enterococcus (vre) ,medicine ,peritonitis ,biology ,business.industry ,Peritoneal fluid ,General Engineering ,biochemical phenomena, metabolism, and nutrition ,medicine.disease ,biology.organism_classification ,peritoneal dialysis ,Nephrology ,Vancomycin ,Daptomycin ,business ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Peritonitis is a well-known complication seen with peritoneal dialysis. Peritonitis is associated with increased mortality risk and is commonly caused by gram-positive and gram-negative bacteria, but it can also be the result of fungal or viral infections. Therefore, it is imperative to obtain a peritoneal fluid sample to send for cell count with differential, gram stain, and culture prior to starting empiric antibiotic therapy. We report a case of peritoneal dialysis-related peritonitis caused by Enterococcus gallinarum, for which there has only been one other reported case in the medical literature. Our patient was initially placed on vancomycin and cefepime but continued to deteriorate until peritoneal fluid cultures revealed E. gallinarum. Based on sensitivities, the patient was treated with daptomycin and cefazolin, which resolved her peritonitis.
- Published
- 2020
6. Incidence, Predictors, Causes, and Cost of 30-Day Hospital Readmission in Chronic Obstructive Pulmonary Disease Patients Undergoing Bronchoscopy
- Author
-
Neel Patel, Jeevanjot Virk, Joseph Quist, Oday Alhafidh, Vijay Gayam, Binav Shrestha, Danilo Enriquez, Jasdeep Singh Sidhu, Frances Schmidt, Osama Mukhtar, Dina Altuhafy, Ramakanth Pata, and Zeel Patel
- Subjects
COPD ,medicine.medical_specialty ,bronchoscopy ,medicine.diagnostic_test ,Exacerbation ,Pulmonology ,Proportional hazards model ,business.industry ,readmission ,Incidence (epidemiology) ,Hazard ratio ,General Engineering ,copd ,medicine.disease ,Confidence interval ,Bronchoscopy ,length of stay ,Internal medicine ,Relative risk ,medicine ,index admission (ia) ,business - Abstract
Introduction Chronic obstructive pulmonary disease (COPD) has a significant disease burden and is among the leading causes of hospital readmissions, adding a significant burden on healthcare resources. The association between 30-day readmission in a COPD patient undergoing bronchoscopy and a wide range of modifiable potential risk factors, after adjusting for sociodemographic and clinical factors, has been assessed, and comparison has been made with COPD patients not undergoing bronchoscopy. Methods We conducted a comprehensive analysis of the 2016 Nationwide Readmission Database (NRD) of 30-day all-cause readmission among COPD patients undergoing bronchoscopy. A Cox’s proportional hazards model was used to obtain independent relative risks of readmission following bronchoscopy in COPD patients as compared to patients not undergoing bronchoscopy. Our primary outcome was the 30-day all-cause readmission rate in both groups. Other secondary outcomes of interest were the 10 most common reasons for readmission, resource utilization, independent predictors of readmission, and relative proportion of comorbidities between the index admission (IA) and the readmission in both groups. Results The overall rate of readmission following bronchoscopy in COPD patients as compared to patients not undergoing bronchoscopy was 17.32% and 15.87%, respectively. The final multivariate model in the bronchoscopy group showed that the variables found to be an independent predictor of readmission were: pulmonary hypertension (hazard ratio [HR] 2.35; 95% confidence interval [CI] 1.26-4.25; P < .01), adrenal insufficiency (HR 4.47; 95% CI 1.44-13.85; P = .01) and discharge to rehab status. Independent predictor variables of admission in Group B were gender (women < men; HR 0.91; 95% CI 0.88-0.93; P < .01), and type of insurance (Medicaid > Medicare > private insurance). For all patients undergoing bronchoscopy, the mean length of stay (LOS) for IA was 11.91 ± 20.21 days, and LOS for readmission was 5.87 ± 5.48 days. The mean total cost of IA for patients undergoing bronchoscopy was much higher than that of readmission ($26,916 vs. $12,374, respectively). The entire LOS for readmission was 1,265 days, with a total cost of $2.66 million. For patients not undergoing bronchoscopy during the IA, mean LOS for IA was 4.26 ± 4.27 days, and mean LOS for readmission was 5.39 ± 5.51 days, which was longer than the IA in Group B but still shorter than LOS for readmission in Group A (patients undergoing bronchoscopy). The mean total cost of readmission was higher than the IA ($8,137 for IA vs. $10,893 for readmission). The total LOS in this group of patients was 313,287 days, with the total cost of readmission at $628 million. Conclusions Patients undergoing bronchoscopy have a slightly higher rate of 30-day readmissions as compared to patients not undergoing bronchoscopy, and the LOS is also slightly higher in this group during subsequent readmissions as compared to readmission in patients not undergoing bronchoscopy in IA. The readmission rate in COPD patients is impacted by a variety of social, personal, and medical factors. Patients with multiple medical comorbidities have a higher risk of readmission. In our understanding, bronchoscopy in a patient with acute exacerbation of COPD should be reserved for selected patients, and the rationale should be clarified, as it affects the overall LOS and healthcare expenditure.
- Published
- 2020
7. Cor Triatriatum Dexter as an Incidental Finding: Role of Two-Dimensional Transthoracic Echocardiography
- Author
-
Zeel Patel, Bikramjit S Bindra, Khushal V Choudhary, Neel Patel, and Vinod Patel
- Subjects
Sinus venosus ,medicine.medical_specialty ,Cor triatriatum dexter ,business.industry ,Cardiology ,General Engineering ,030204 cardiovascular system & hematology ,CONGENITAL CARDIAC ANOMALY ,ctd ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Internal medicine ,Internal Medicine ,cardiovascular system ,medicine ,Right atrium ,CTD ,business ,030217 neurology & neurosurgery ,cor triatriatum dexter - Abstract
Cor triatriatum dexter (CTD) is a rare congenital cardiac anomaly in which a membranous structure divides the right atrium (RA) into two chambers. Persistence of the right valve of the sinus venosus, which usually regresses as a part of normal embryological development, is responsible for membranous partition. There is a high incidence of right-sided congenital abnormalities of the heart associated with this condition. Clinical manifestations vary depending on the degree of partitioning or septation of the RA. We present a case of CTD discovered as an incidental finding during transthoracic echocardiography and further discuss the role of two-dimensional echocardiography as a noninvasive diagnostic tool.
- Published
- 2019
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.